Inductive Bio gives drug hunters a virtual lab where AI chemistry assistants run millions of experiments to identify safer, stronger development candidates.

Products & media

Compass

A virtual laboratory workspace where medicinal chemists run predictive experiments, review ADMET results, and prioritize compounds for synthesis.

Indy

An AI chemistry assistant that manages program operations, validates experimental data, analyzes structure-activity patterns, and proposes tractable compound designs.

AI-Integrated Synthesis

A managed synthesis service combining AI oversight, route planning, compound tracking, predictive ADMET, and execution through partner chemistry organizations.

Beacon-1

A class of program-tuned machine-learning models that predicts ADMET properties across heterogeneous small-molecule datasets and evolving chemical spaces.

Embedded Experts

A drug-discovery service providing dedicated medicinal chemistry, computational chemistry, and DMPK specialists who operate Inductive's virtual laboratory for partners.

ADME-One

A high-throughput experimental service delivering five Tier 1 ADME assays with AI-contextualized human pharmacokinetic projections for each compound.

Cosigns

Jay RughaniPartner at Andreessen Horowitz
“Congrats to the Nested Tx and Inductive Bio teams on this successful collaboration showing how new AI models can predict ADME properties and accelerate small molecule drug discovery.”
Source
Gil ShklarskiBuilding Gravity Systems; General Partner at Operator Partners
“As an early angel investor, it has been fun watching their company grow into a platform that accelerates the discovery of life-changing therapeutics.”
Source
E.G. Blee-GoldmanCo-Founder and General Partner at Character; early-stage investor focused on design sprints.
“Inductive helps scientists create safer & more effective drugs using AI. Amazingly, @Just_Joshing & @benbirnbaum's idea is this all happens before the drug is created.”
Source

Team

2 people across company lists

Jobs

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Data current as of May 7, 2025

Leads

Participating Firms

Angels